Literature DB >> 11762318

Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes.

N Sodeyama, H Mizusawa, M Yamada, Y Itoh, E Otomo, M Matsushita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11762318      PMCID： PMC1737626          DOI： 10.1136/jnnp.71.6.817

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  11 in total

Review 1.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

2.  Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk.

Authors:  Mia E Blomqvist; Shane McCarthy; Kaj Blennow; Björn Andersson; Jonathan A Prince
Journal:  Int J Mol Epidemiol Genet       Date:  2010-10-15

3.  Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.

Authors:  Scott Miners; Zoë van Helmond; Rachel Barker; Peter A Passmore; Janet A Johnston; Stephen Todd; Bernadette M McGuinness; Francesco Panza; Davide Seripa; Vincenzo Solfrizzi; Seth Love; Jonathan A Prince; Patrick G Kehoe
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-05

4.  Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.

Authors:  John B Rose; Leslie Crews; Edward Rockenstein; Anthony Adame; Michael Mante; Louis B Hersh; Fred H Gage; Brian Spencer; Rewati Potkar; Robert A Marr; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

5.  Association of neprilysin polymorphism with cerebral amyloid angiopathy.

Authors:  M Yamada; N Sodeyama; Y Itoh; A Takahashi; E Otomo; M Matsushita; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

6.  A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; David I Graham; Janice E Stewart; Amy H Praestgaard; Douglas H Smith
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

7.  Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

Authors:  Robert A Marr; Edward Rockenstein; Atish Mukherjee; Mark S Kindy; Louis B Hersh; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

8.  beta-Amyloid degradation and Alzheimer's disease.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  J Biomed Biotechnol       Date:  2006

Review 9.  Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.

Authors:  Marcus O W Grimm; Janine Mett; Christoph P Stahlmann; Viola J Haupenthal; Valerie C Zimmer; Tobias Hartmann
Journal:  Front Aging Neurosci       Date:  2013-12-23       Impact factor: 5.750

10.  Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.

Authors:  Brian Spencer; Robert A Marr; Edward Rockenstein; Leslie Crews; Anthony Adame; Rewati Potkar; Christina Patrick; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  BMC Neurosci       Date:  2008-11-12       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.